Diamond Pharmacy Services names Matthew Risko a 340B Apexus Certified Expert

Diamond Pharmacy Services says Correctional Director Matthew Risko earned the 340B Apexus Certified Expert designation through Apexus’ Advanced 340B Operations Certificate Program. The certification adds specialized 340B expertise to Diamond’s correctional pharmacy and consulting work as healthcare organizations face tighter compliance and cost pressures.

Why it matters: - The 340B ACE designation signals advanced expertise in 340B operations, compliance and best practices. - Diamond Pharmacy Services says the credential strengthens its ability to guide correctional facilities and healthcare partners that rely on 340B pricing to support vulnerable patients and stretch limited resources. - For correctional healthcare organizations, deeper 340B knowledge can affect medication access, formulary management, cost containment and regulatory compliance.

What happened: - Diamond Pharmacy Services announced that Matthew Risko, BS, RPh, AAHIVP, earned the 340B Apexus Certified Expert designation on Aug. 11, 2026. - Risko serves as Correctional Director of Executive Consultant Pharmacists and Clinical-340B Project Development. - The certification came through the Apexus Advanced 340B Operations Certificate Program. - Risko leads Diamond's Executive Consultant Pharmacists, the OPTICS (Office of Pharmacy Therapeutics and Integrated Clinical Services) Board Certified PharmD Clinical teams and the company's 340B partner initiatives. - Diamond highlighted Risko's role in supporting correctional executive leadership, medical teams and 340B covered entity partners nationwide.

The details: - The 340B Program allows a correctional system to partner with a covered entity to access discounted outpatient medications. - Diamond said those savings can help improve patient care and help maintain, improve and expand services for medically vulnerable patients. - The 340B ACE credential is awarded to professionals who demonstrate a comprehensive understanding of 340B program operations, compliance requirements and industry best practices. - Diamond said Risko's work includes navigating pharmacy formulary management, cost containment opportunities and regulatory requirements. - CEO Mark Zilner said Risko continues to look for ways to expand his knowledge and bring more value to clients. - Zilner also said the evolving 340B landscape makes the certification important for helping correctional healthcare organizations and covered entities navigate challenges with confidence. - Risko said the certification was an opportunity to deepen his understanding of 340B operations and stay current with changes affecting healthcare organizations nationwide. - Risko said he plans to apply the training to help partners strengthen programs, meet compliance expectations, prepare for possible regulatory hurdles and support better patient care. - Diamond describes itself as the nation's largest correctional pharmacy. - The company provides pharmacy services, clinical support, consulting and technology solutions to correctional healthcare organizations nationwide.

Between the lines: - The announcement is as much about Diamond's consulting footprint as one employee's credential. - The company is signaling that 340B expertise is becoming a competitive advantage as rules, pricing and compliance demands grow more complex. - The focus on correctional healthcare suggests Diamond is targeting a niche where medication access and regulatory discipline are especially important.

What's next: - Diamond is likely to lean more heavily on Risko's certification in future 340B consulting and correctional healthcare support. - The company says it will continue investing in clinical and operational expertise to help partners adapt to a more complex regulatory environment. - Diamond directs readers to learn more about the company. - The company also maintains a LinkedIn presence.